About this compound
KPV is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone, corresponding to residues 11-13 of the parent sequence. At three residues it is the shortest peptide in the PeptideSeed catalogue.
Studied in
- Inflammatory signalling
- Cutaneous models
- Intestinal barrier research
Compound identity
| Compound | KPV |
|---|---|
| CAS number | 64231-00-3 |
| Molecular formula | C22H33N5O4 |
| Molecular weight | 431.53 Da |
Specifications
- Purity method: HPLC
- Appearance: Lyophilized powder
- Solubility: Reconstitute per protocol; see Supplies for diluents.
- We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.
Regenerative
TROJAN
KPV
Alpha-MSH tripeptide fragment, studied in inflammatory models.
What the research targets
Studied in cutaneous and intestinal inflammatory models for its anti-inflammatory signalling.
Supply formats
Single units ship from stock. Cases are back-ordered against the same single-unit price.
Stick is newly released — available alongside the vial on every compound.
Single unit
Sample quantity — one unit.
10 mgVial
PS-3255068-10-MG
On verified accountSkinni Stick™ 10 mgSkinni Stick™New
Single-compound Skinni Stick™. Supplied to verified accounts only.
PS-3255068-PEN-10-MG
On verified account
Case — back-order
Ten of one size, at 10× volume pricing.
Case · 10 × 10 mg
Back-order — 15% off the single-unit price.
PS-3255068-C10-10-MG
On verified accountCase · 10 × Skinni Stick™ 10 mgNew
Back-order — 15% off the single-unit price.
PS-3255068-C10-PEN-10-MG
On verified account
One-time verification of professional or institutional affiliation. No payment is taken on this site.
Research use only
This compound is supplied exclusively for laboratory research by qualified professionals and institutions. It is not a drug, dietary supplement, or cosmetic, and is not for human or veterinary use. We publish no dosing, administration, or human-use guidance of any kind, and nothing here should be read as a claim about an effect in people.
From the research library
Cited summaries of the published work behind KPV — what was studied, in which model, and what was measured.
Cellular
Thymic peptides: an immunomodulator with a long paper trail
Thymosin alpha-1 has been studied since the 1970s, is licensed in a number of countries, and has a mechanistic account centred on Toll-like receptor signalling.
Regenerative
PepT1, and a three-residue fragment of a larger hormone
KPV is the C-terminal tripeptide of alpha-MSH. The interesting part of its literature is how it gets into a cell.
More in Regenerative
SENTINEL
BPC-157
Studied in soft-tissue and gastrointestinal repair models, and in angiogenesis signalling.
VERDIGRIS
GHK-Cu
Studied in dermal fibroblast models for extracellular-matrix and collagen signalling, and in follicular research.
LUMEN
Glow Blend
Supplied as a single reconstitution for protocols that study GHK-Cu, BPC-157 and TB-500 together in skin and repair models.